ACAD — ACADIA PHARMACEUTICALS INC

Ownership history in RICE HALL JAMES & ASSOCIATES, LLC  ·  24 quarters on record

AI Ownership Summary

RICE HALL JAMES & ASSOCIATES, LLC reported ACADIA PHARMACEUTICALS INC (ACAD) in 24 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 1.26% in 2023 Q4. The latest visible filing shows ACAD at 0.89% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this ACAD ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was RICE HALL JAMES & ASSOCIATES, LLC's position in ACADIA PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

ACAD was reported at 0.89% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.26% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

ACAD stock page RICE HALL JAMES & ASSOCIATES, LLC fund profile RICE HALL JAMES & ASSOCIATES, LLC full holdings
How RICE HALL JAMES & ASSOCIATES, LLC held ACAD — position size vs. price
% of Fund (quarterly)    ACAD price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  ▾
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 603,740 -11,197 -1.8% 0.89% $16.1M 2026-02-14 (Est.) $22.03
2025 Q3 REDUCED 614,937 -54,869 -8.2% 0.72% $13.1M 2025-10-16 $20.62
2025 Q2 REDUCED 669,806 -2,417 -0.4% 0.78% $14.4M 2025-08-11 $24.82
2025 Q1 REDUCED 672,223 -9,314 -1.4% 0.66% $11.2M 2025-05-01 $14.57
2024 Q4 REDUCED 681,537 -35,609 -5.0% 0.69% $12.5M 2025-01-31 $18.66
2024 Q3 REDUCED 717,146 -25,789 -3.5% 0.60% $11.0M 2024-10-28 $14.74
2024 Q2 ADDED 742,935 +78,379 +11.8% 0.72% $12.1M 2024-08-07 $15.17
2024 Q1 REDUCED 664,556 -28,296 -4.1% 0.70% $12.3M 2024-04-23 $16.74
2023 Q4 REDUCED 692,852 -3,213 -0.5% 1.26% $21.7M 2024-02-09 $26.36
15 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding ACAD

As of 2026 Q1 — sorted by position size

Axecap Investments, LLC 2.34% PSP Research LLC 0.31% Yorktown Management & Research Co Inc 3Y 7Y 0.22% Uniting Wealth Partners, LLC 0.05% WESBANCO BANK INC 3Y 7Y 0.05% Pictet Asset Management Holding SA 0.05% NJ State Employees Deferred Compensation Plan 3Y 7Y 0.04% CONGRESS ASSET MANAGEMENT CO 3Y 7Y 0.03% Violich Capital Management, Inc. 3Y 7Y 0.02% State of Alaska, Department of Revenue 3Y 7Y 0.02%

FAQ About RICE HALL JAMES & ASSOCIATES, LLC and ACAD

These are the practical questions this page is built to answer before you even open the full history table.

How long has RICE HALL JAMES & ASSOCIATES, LLC reported owning ACAD?

RICE HALL JAMES & ASSOCIATES, LLC reported ACAD across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported ACAD position in RICE HALL JAMES & ASSOCIATES, LLC's portfolio?

The largest reported portfolio weight for ACAD was 1.26% in 2023 Q4.

What is the latest reported ACAD position on this page?

The most recent filing on this page is 2025 Q4, when RICE HALL JAMES & ASSOCIATES, LLC reported 603,740 shares, equal to 0.89% of portfolio, with an estimated market value of $16.1M.

What does the chart on this ACAD ownership page compare?

The chart compares RICE HALL JAMES & ASSOCIATES, LLC's quarterly ACAD portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to RICE HALL JAMES & ASSOCIATES, LLC Holdings